337 related articles for article (PubMed ID: 10629063)
1. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
Liu HX; Chew SL; Cartegni L; Zhang MQ; Krainer AR
Mol Cell Biol; 2000 Feb; 20(3):1063-71. PubMed ID: 10629063
[TBL] [Abstract][Full Text] [Related]
2. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR
Mol Cell Biol; 1999 Mar; 19(3):1853-63. PubMed ID: 10022872
[TBL] [Abstract][Full Text] [Related]
4. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
Zhu J; Mayeda A; Krainer AR
Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
[TBL] [Abstract][Full Text] [Related]
5. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
Tacke R; Manley JL
EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
[TBL] [Abstract][Full Text] [Related]
6. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
7. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
[TBL] [Abstract][Full Text] [Related]
9. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins.
Liu HX; Zhang M; Krainer AR
Genes Dev; 1998 Jul; 12(13):1998-2012. PubMed ID: 9649504
[TBL] [Abstract][Full Text] [Related]
10. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.
Zahler AM; Damgaard CK; Kjems J; Caputi M
J Biol Chem; 2004 Mar; 279(11):10077-84. PubMed ID: 14703516
[TBL] [Abstract][Full Text] [Related]
11. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences.
Schaal TD; Maniatis T
Mol Cell Biol; 1999 Mar; 19(3):1705-19. PubMed ID: 10022858
[TBL] [Abstract][Full Text] [Related]
12. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.
Rooke N; Markovtsov V; Cagavi E; Black DL
Mol Cell Biol; 2003 Mar; 23(6):1874-84. PubMed ID: 12612063
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.
Chew SL; Liu HX; Mayeda A; Krainer AR
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10655-60. PubMed ID: 10485881
[TBL] [Abstract][Full Text] [Related]
14. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Liu X; Mayeda A; Tao M; Zheng ZM
J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
[TBL] [Abstract][Full Text] [Related]
16. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.
Smith PJ; Zhang C; Wang J; Chew SL; Zhang MQ; Krainer AR
Hum Mol Genet; 2006 Aug; 15(16):2490-508. PubMed ID: 16825284
[TBL] [Abstract][Full Text] [Related]
17. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
[TBL] [Abstract][Full Text] [Related]
18. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
[TBL] [Abstract][Full Text] [Related]
19. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.
Sun Q; Mayeda A; Hampson RK; Krainer AR; Rottman FM
Genes Dev; 1993 Dec; 7(12B):2598-608. PubMed ID: 8276242
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone deficiency and splicing fidelity: two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically.
Solis AS; Peng R; Crawford JB; Phillips JA; Patton JG
J Biol Chem; 2008 Aug; 283(35):23619-26. PubMed ID: 18586677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
